healthi put st bear
argument bed
dear client appreci consider institut investor all-america
 all-canada research survey view analyst pleas click
believ healthi result go long way get investor excit
salesforc period rel under-perform recent month mani
bearish point rais certain investor address turn
stori actual simpl healthi growth scale driven larg
superior execut continu view salesforc core hold
space offer healthi growth reason valuat level henc reiter
ow rate top pick design rais pt
number salesforc deliv revenu growth y/i cci bill growth
vs consensu crpo grew y/i cci vs guidanc
impli st book growth y/i vs top-lin
guidanc came slightli ahead consensu ep guidanc impact
acquisit manag reiter guidanc across board
revenu oper margin expans
posit bill beat vs expect highlight
quarter manag reiter guidanc despit fx headwind
year strong cash flow out-performance cfo growth vs
consensu due healthi collect beat oper margin
vs consensu highlight underli leverag model
neg weaker-than-expect ep guidanc due headwind
acquisit report crpo growth came light expect due
fx headwind quarter cfo guidanc reiter despit
strong beat quarter like reflect manag conservat
potenti catalyst salesforc connect confer chicago june
earn tent august
quarterli annual ep usd
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
rais usd
return equiti ttm
link barclay live interact chart
overweight like larg scale sale
busi expect strong growth
continu also like move
applic market custom servic
market cloud
new area salesforc expand
market mobil well
greater enterpris industri focu could drive
growth current expect
move new market area may pay
lead growth slowdown still
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
salesforc report healthi result bill beat main highlight
compani deliv beat revenu grew cci adjust
annual fx headwind note strong ep beat driven benefit
mtm strateg invest
summari compani complet result quarter vs barclay consensu
estim pleas refer figur
summari actual vs barclay consensu estim
compani provid guidanc reiter guidanc top-lin guidanc
came slightli ahead expect ep guidanc neg impact
revenu contribut
detail summari compani guidanc versu estim
consensu pleas refer figur
summari compani guidanc vs consensu estim previou barclay estim
compani data streetaccount refinitiv
in-lin crpo adjust fx healthi product segment perform
crpo grew y/i quarter adjust fx headwind crpo growth
in-lin guidanc st book revenu sequenti chang crpo grew
vs also note manag guid crpo growth
would impli crpo rel flat q/q would expect upsid base
histor sequenti growth see chart q/q last year also given
expect crpo contribut
barclayscon vs servic profit oper profit net incom barclay inc
crpo y/i growth bn
compani deliv broad-bas solid execut across region america
grow y/i cci europ asia also show growth across
cloud segment chart note mulesoft continu meaning
outperform expect contribut subscript support revenu
revenu growth segment
compani data barclay research salesforc platform growth exclud mulesoft
valuat estim chang
detail chang model follow manag guidanc
commentari pleas see tabl remain posit long-term opportun
reiter overweight rate rais pt slightli
reflect chang fdso net debt pt base unchang
ev/ rel unchang
cloudservic cloudmarket cloudsalesforc platform growth barclay inc
summari estim chang
profession servic total subscript profession servic total cost gross profit base profit research market gener total oper oper profit ebitda expens incom outstand adjust adjust barclay inc
asset cash term market current assetsmarket equip softwar intang non-curr liabilitiesaccount payabl accru current liabilitiesunearn non-curr sharehold liabil net oper combin net activ build market invest issuanc financ chang barclay inc
raimo lenschow cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
price sourc refinitiv last avail close price relev trade market unless anoth time sourc indic
